Intrinsiqs

Is Amneal Pharmaceuticals, Inc. overvalued?

Amneal Pharmaceuticals, Inc. (AMRX) looks undervalued — trading about 42% below its fair value.

Undervalued
Current price $21.38 Fair value $30.33
Price
$21.38
Fair value
$30.33
Current P/E
23.8
Normal P/E
33.7
Market cap
$7.45B
Dividend yield
0.0%
Return on equity
131.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AMRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.